PCI in the patient with sole remaining conduit

Percutaneous coronary intervention Microchapters
Home
Patient Information
Overview
Risk Stratification and Benefits of PCI
Preparation of the Patient for PCI
Equipment Used During PCI
Pharmacotherapy to Support PCI
Vascular Closure Devices
Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT
Post-PCI Management
Risk Reduction After PCI
Post-PCI follow up
Hybrid coronary revascularization
PCI approaches
PCI Complications
Factors Associated with Complications Vessel Perforation Dissection Distal Embolization No-reflow Coronary Vasospasm Abrupt Closure Access Site Complications Peri-procedure Bleeding Restenosis Renal Failure Thrombocytopenia Late Acquired Stent Malapposition Loss of Side Branch Multiple Complications
PCI in Specific Patients
Cardiogenic Shock Left Main Coronary Artery Disease Refractory Ventricular Arrhythmia Severely Depressed Ventricular Function Sole Remaining Conduit Unprotected Left Main Patient Adjuncts for High Risk PCI
PCI in Specific Lesion Types
Classification of the Lesion The Calcified Lesion The Ostial Lesion The Angulated or Tortuous Lesion The Bifurcation Lesion The Long Lesion The Bridge Lesion Vasospasm The Chronic Total Occlusion The Left Internal Mammary Artery Multivessel Disease Distal Anastomotic Lesions Left Main Intervention The Thrombotic Lesion
PCI in the patient with sole remaining conduit On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of PCI in the patient with sole remaining conduit All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on PCI in the patient with sole remaining conduit
CDC on PCI in the patient with sole remaining conduit
PCI in the patient with sole remaining conduit in the news
Blogs on PCI in the patient with sole remaining conduit
Directions to Hospitals Treating Percutaneous coronary intervention
Risk calculators and risk factors for PCI in the patient with sole remaining conduit

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Vijayalakshmi Kunadian MBBS, MD, MRCP

PCI in the Patient with Sole Remaining Conduit

Sole remaining conduit (SRC) refers to the only remaining artery (native artery or bypass graft) with occlusion of the native and bypass supplies to the remaining two coronary arteries. There are insufficient data on percutaneous coronary intervention to a sole remaining conduit.

When patients with SRC present with severe anginal symptoms, there are three options to deal with these patients. First, perform PCI through and to the SRC. Second, to perform PCI to one or more chronic total occlusions and finally, to optimize patients with medical therapy. Other adjunct devices such as intra-aortic balloon pump may be beneficial in this setting.

Tavano et al studied 16 patients who underwent percutaneous coronary intervention in their sole remaining vessel. All patients were symptomatic with unstable angina or minimal effort angina refractory to maximal medical therapy. In-hospital, one-month and 6-month major adverse cardiac events (defined as the composite of death, myocardial infarction, and target vessel revascularization) and angina status according to the Canadian Cardiovascular Society (CCS) score were assessed. During hospital stay one patient died 10 hours after the procedure secondary to acute pulmonary edema, urgent coronary angiography showed a patent target vessel. At one month 75% of patients were asymptomatic, the other 3 patients experienced symptom improvement from CCS III to I. After 6 months, a second patient died after an out-of-hospital cardiac arrest that occurred 4 months after the procedure. At one year, there were no additional deaths, one patient developed non-Q wave myocardial infarction and one patient underwent repeat PCI of the target vessel.

Conclusion

There is limited data on PCI to the sole remaining conduit. Small retrospective analysis support PCI as a treatment strategy for highly symptomatic and difficult-to-treat patient cohort.